<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="letter" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">OURD</journal-id>
<journal-title>Our Dermatol Online</journal-title>
<issn pub-type="epub">2081-9390</issn>
<publisher>
<publisher-name>Our Dermatology Online</publisher-name>
<publisher-loc>Poland</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">OURD-6-235</article-id>
<article-id pub-id-type="doi">10.7241/ourd.20152.63</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Letter to the Editor</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Recurrent targetoid hemosiderotic hemangioma</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>&#x00C7;akmak</surname>
<given-names>Seray K&#x00FC;lc&#x00FC;</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="corresp" rid="cor1"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>G&#x00FC;ne&#x015F;</surname>
<given-names>R&#x0131;dvan</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tamer</surname>
<given-names>Emine</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Art&#x00FC;z</surname>
<given-names>Ferda</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>&#x00C7;ift&#x00E7;i</surname>
<given-names>Ay&#x015F;e Y&#x0131;lmaz</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label><italic>Dermatology Clinic, Ankara Numune Education and Research Hospital, Ankara, Turkey</italic></aff>
<aff id="aff2"><label>2</label><italic>Pathology Clinic, Ankara Numune Education and Research Hospital, Ankara, Turkey</italic></aff>
<author-notes>
<corresp id="cor1">
<bold>Corresponding author:</bold> Assoc. Prof. Seray K&#x00FC;lc&#x00FC; &#x00C7;akmak, E-mail: <email xlink:href="seraycakmak@gmail.com">seraycakmak@gmail.com</email>
</corresp>
</author-notes>
<pub-date pub-type="ppub">
<year>2015</year>
</pub-date>
<volume>6</volume>
<issue>2</issue>
<fpage>235</fpage>
<lpage>236</lpage>
<history>
<date date-type="received"><day>14</day><month>11</month><year>2014</year></date>
<date date-type="accepted"><day>29</day><month>01</month><year>2015</year></date>
</history>
<permissions>
<copyright-statement>Copyright: &#x000a9; Our Dermatol Online 2</copyright-statement>
<copyright-year>2015</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p>
</license>
</permissions>
</article-meta>
</front>
<body>
<sec id="sec1-1">
<title/>
<p>Sir,</p>
<p>Targetoid hemosiderotic hemangioma (THH) which is also known as hobnail hemangioma is a rare benign vascular neoplasm [<xref ref-type="bibr" rid="ref1">1</xref>]. Although episodic and cyclic morphological changes can occur, spontaneous regression and recurrence is very rarely reported [<xref ref-type="bibr" rid="ref2">2</xref>,<xref ref-type="bibr" rid="ref3">3</xref>]. We report a case of THH that recurred after previous complete resolution.</p>
</sec>
<sec id="sec1-2" sec-type="cases">
<title>CASE REPORT</title>
<p>A 43-year-old women presented with a 5-mm violaceous papule with a surrounding annular, eccymotic halo on the right side of the flank (<xref ref-type="fig" rid="F1">Fig. 1</xref>). The patient stated that the lesion had appeared 1-week ago. She described the onset of a similar lesion at the same place 1-year ago and the lesion had regressed completely within 2 months without any treatment. The patients past medical history included diabetes mellitus, depression and lower extremity venous insufficiency and she had been using metmofine, sertraline and calcium dobesilat therapies. The patient did not give any history of trauma to the area of the lesion. Histopathology of the lesion revealed ectatic vascular spaces lined with a single layer of prominent plump endothelial cells protruding in to the lumen of vessels and the patient was diagosed as THH (<xref ref-type="fig" rid="F1">Fig. 2</xref>).</p>
<fig id="F1">
<label>Figure 1</label>
<caption>
<p>Violaceous papule with a surrounding annular, eccymotic halo</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="OURD-6-235-g001.tif"/>
</fig>
<fig id="F2">
<label>Figure 2</label>
<caption>
<p>Ectatic vascular spaces which lined with a single layer of prominent plump endothelial cells protruding in to the lumen of vessels (H&#x0026;EX20)</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="OURD-6-235-g002.tif"/>
</fig>
<p>The patient&#x2019;s informed consent was obtained.</p>
<p>Prior to the study, patient gave written consent to the examination and biopsy after having been informed about the procedure</p>
</sec>
<sec id="sec1-3" sec-type="discussion">
<title>DISCUSSION</title>
<p>THH is a solitary vascular neoplasm which was first described by Santa Cruz and Aronburg in 1988 [<xref ref-type="bibr" rid="ref4">4</xref>]. Though the etiology of THH is not clear trauma to a pre-existing hemangioma and influence of sex hormones have been proposed [<xref ref-type="bibr" rid="ref5">5</xref>,<xref ref-type="bibr" rid="ref6">6</xref>]. THH occurs predominanly on the proximal extremities and trunk and often presents as a small violaceous papule or nodule with an ecchymotic halo, which leads to a targetoid appearance [<xref ref-type="bibr" rid="ref2">2</xref>,<xref ref-type="bibr" rid="ref3">3</xref>]. The halo may expand peripherally and eventually disappear [<xref ref-type="bibr" rid="ref3">3</xref>]. However the halo may not be present in all cases and the term hobnail hemangioma is used to describe the non-targetoid variant [<xref ref-type="bibr" rid="ref2">2</xref>]. Cyclic changes have been described in palpability, size and color of THH [<xref ref-type="bibr" rid="ref5">5</xref>,<xref ref-type="bibr" rid="ref7">7</xref>].</p>
<p>Histopathologically ectatic vascular spaces which are often lined with a single layer of prominent plump endothelial cells protruding in to the lumen of vessels are observed in the papillary dermis and vascular spaces and collagen dissecting narrow vessels are observed in the deeper dermis [<xref ref-type="bibr" rid="ref5">5</xref>,<xref ref-type="bibr" rid="ref6">6</xref>].</p>
<p>The clinical differantial diagnosis includes melanocytic nevus, melanoma, dermatofibroma, hemangioma, insect bite reaction and the histopathological differential diagnosis includes Kaposi&#x2019;s sarcoma, retiform hemangioendothelioma, eosinophilic hemangioma, progressive lymphangioma and angiokeratoma [<xref ref-type="bibr" rid="ref6">6</xref>,<xref ref-type="bibr" rid="ref7">7</xref>].</p>
<p>THH may be removed for diagnostic and cosmetic purposes and there is no recurrence after excision [<xref ref-type="bibr" rid="ref3">3</xref>].</p>
<p>We present this case as complete and spontaneous regression with subsequent recurrence has been very rarely reported in the literature.</p>
</sec>
<sec id="sec1-4">
<title>CONSENT</title>
<p>The examination of the patient was conducted according to the Declaration of Helsinki principles. Written informed consent was obtained from the patient for publication of this article</p>
</sec>
</body>
<back>
<ref-list>
<title>REFERENCES</title>
<ref id="ref1">
<label>1</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>JM</given-names>
</name>
</person-group>
<article-title>Targetoid hemosiderotic hemangioma (Hobnail Hemangioma): Typical clinical and histological presentation</article-title>
<source>Chin Med J</source>
<year>2013</year>
<volume>126</volume>
<fpage>3399</fpage>
</nlm-citation>
</ref>
<ref id="ref2">
<label>2</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tan</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>WY</given-names>
</name>
<name>
<surname>Lai</surname>
<given-names>RS</given-names>
</name>
</person-group>
<article-title>A recurrent case of targetoid hemosiderotic haemangioma</article-title>
<source>Acta Derm Venereol</source>
<year>2008</year>
<volume>88</volume>
<fpage>181</fpage>
<lpage>2</lpage>
</nlm-citation>
</ref>
<ref id="ref3">
<label>3</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gendernalik</surname>
<given-names>SB</given-names>
</name>
<name>
<surname>Gendernalik</surname>
<given-names>JD</given-names>
</name>
</person-group>
<article-title>Recurrent targetoid hemosiderotic hemangioma in a 26-year-old man</article-title>
<source>J Am Osteopath Assoc</source>
<year>2011</year>
<volume>111</volume>
<fpage>117</fpage>
<lpage>8</lpage>
</nlm-citation>
</ref>
<ref id="ref4">
<label>4</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Santa</surname>
<given-names>Cruz DJ</given-names>
</name>
<name>
<surname>Aronberg</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Targetoid hemosiderotic hemangioma</article-title>
<source>J Am Acad Dermatol</source>
<year>1988</year>
<volume>19</volume>
<fpage>550</fpage>
<lpage>8</lpage>
</nlm-citation>
</ref>
<ref id="ref5">
<label>5</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Al Dhaybi</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Lam</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Hatami</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Powell</surname>
<given-names>J</given-names>
</name>
<name>
<surname>McCuaig</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kokta</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>Targetoid hemosiderotic hemangiomas (hobnail hemangiomas) are vascular lymphatic malformations: A study of 12 pediatric cases</article-title>
<source>J Am Acad Dermatol</source>
<year>2012</year>
<volume>66</volume>
<fpage>116</fpage>
<lpage>20</lpage>
</nlm-citation>
</ref>
<ref id="ref6">
<label>6</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoon</surname>
<given-names>SY</given-names>
</name>
<name>
<surname>Kwon</surname>
<given-names>HH</given-names>
</name>
<name>
<surname>Jeon</surname>
<given-names>HC</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Congenital and multiple hobnail hemangiomas</article-title>
<source>Ann Dermatol</source>
<year>2011</year>
<volume>23</volume>
<fpage>539</fpage>
<lpage>43</lpage>
</nlm-citation>
</ref>
<ref id="ref7">
<label>7</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sahin</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Demir</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Gunduz</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ozturkcan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>T&#252;rel-Ermertcan</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Targetoid haemosiderotic haemangioma: Dermoscopic monitoring of three cases and review of the literature</article-title>
<source>Clin Exp Dermatol</source>
<year>2005</year>
<volume>30</volume>
<fpage>672</fpage>
<lpage>6</lpage>
</nlm-citation>
</ref>
</ref-list>
<fn-group>
<fn fn-type="supported-by">
<p><bold>Source of Support:</bold> Nil</p>
</fn>
<fn fn-type="conflict">
<p><bold>Conflict of Interest:</bold> None declared.</p>
</fn>
</fn-group>
</back>
</article>